EP 0799049 A1 19971008 - COSMETIC OR PHARMACEUTICAL AND PARTICULARLY DERMATOLOGICAL COMPOSITION, AND CULTURE MEDIUM CONTAINING A -i(SMELOPHYLLUM CAPENSE) EXTRACT
Title (en)
COSMETIC OR PHARMACEUTICAL AND PARTICULARLY DERMATOLOGICAL COMPOSITION, AND CULTURE MEDIUM CONTAINING A -i(SMELOPHYLLUM CAPENSE) EXTRACT
Title (de)
KOSMETISCHE ODER PHARMAZEUTISCHE ZUSAMMENSETZUNG, INSBESONDERE DERMATOLOGISCH UND KULTURMEDIUM, DIE EIN SMELOPHYLLUM CAPENSE EXTRAKT ENTHALTEN
Title (fr)
COMPOSITION COSMETIQUE OU PHARMACEUTIQUE, NOTAMMENT DERMATOLOGIQUE ET MILIEU DE CULTURE, CONTENANT UN EXTRAIT DE SMELOPHYLLUM CAPENSE
Publication
Application
Priority
- FR 9501724 W 19951222
- FR 9415576 A 19941223
Abstract (en)
[origin: US5807555A] PCT No. PCT/FR95/01724 Sec. 371 Date Jun. 18, 1997 Sec. 102(e) Date Jun. 18, 1997 PCT Filed Dec. 22, 1995 PCT Pub. No. WO96/20000 PCT Pub. Date Jul. 4, 1996The present invention relates to a method and composition for topically administering a Smelophyllum capense extract as a cosmetic, dermatologic, or pharmaceutical composition to promote collagen synthesis. Administration of the composition results in the firming of the skin, improves healing and is suitable for treating various pathologies accompanied with a deficiency in collagen. The extract can also be added to cell culture medium used in the culture of skin cells, particularly skin fibroblasts. The composition can contain between 0.0001% and 1% by weight of the Smelophyllum capense extract, and the extract can be obtained by extraction with a polar solvent. The composition can contain other ingredients including ascorbic acid, madecassic acid, asiatic acid, madecassoside, asiaticoside, alpha-1-protease inhibitor, collagenase inhibitors, elastase inhibitors, lysine, proline, 2-oxoglutarate and ginsenoside Ro.
IPC 1-7
IPC 8 full level
A61K 8/96 (2006.01); A61K 8/00 (2006.01); A61K 8/44 (2006.01); A61K 8/73 (2006.01); A61K 8/97 (2006.01); A61K 31/70 (2006.01); A61K 36/00 (2006.01); A61K 36/18 (2006.01); A61K 36/77 (2006.01); A61P 17/00 (2006.01); A61Q 19/00 (2006.01); A61Q 19/08 (2006.01); C12N 5/00 (2006.01)
CPC (source: EP US)
A61K 8/9789 (2017.07 - EP US); A61K 36/77 (2013.01 - EP US); A61P 17/00 (2017.12 - EP); A61Q 19/08 (2013.01 - EP US); A61K 2800/782 (2013.01 - EP US)
Citation (search report)
See references of WO 9620000A1
Designated contracting state (EPC)
BE CH DE ES FR GB IT LI
DOCDB simple family (publication)
US 5807555 A 19980915; EP 0799049 A1 19971008; FR 2728465 A1 19960628; FR 2728465 B1 19970314; JP H10511380 A 19981104; WO 9620000 A1 19960704
DOCDB simple family (application)
US 84945397 A 19970618; EP 95943268 A 19951222; FR 9415576 A 19941223; FR 9501724 W 19951222; JP 52026095 A 19951222